Premium
Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium
Author(s) -
Klingensmith Georgeanna J.,
Connor Crystal G.,
Ruedy Katrina J.,
Beck Roy W.,
Kollman Craig,
Haro Heidi,
Wood Jamie R.,
Lee Joyce M.,
Willi Steven M.,
Cengiz Eda,
Tamborlane William V.
Publication year - 2016
Publication title -
pediatric diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 75
eISSN - 1399-5448
pISSN - 1399-543X
DOI - 10.1111/pedi.12281
Subject(s) - medicine , interquartile range , diabetic ketoacidosis , metformin , type 2 diabetes , diabetes mellitus , body mass index , pediatrics , type 1 diabetes , insulin , family history , endocrinology
Objective Type 2 diabetes ( T2D ) in youth is recognized as a pediatric disease, but few reports describe the characteristics during diagnosis. We describe the clinical presentation of 503 youth with T2D . Methods The Pediatric Diabetes Consortium ( PDC ) T2D Clinic Registry enrolled T2D participants from eight pediatric diabetes centers in the USA. Clinical and laboratory characteristics at the time of diagnosis were analyzed. Results In total 67% presented with symptoms of diabetes and confirming laboratory data, but 33% were identified by testing at risk children, 11% presented with diabetic ketoacidosis ( DKA ), and 2% with hyperglycemic hyperosmolar state ( HHS ). The mean age was 13.1 ± 2.3 yr (range, 4.6–19.8 yr) with 38 (8%) less than 10 yr of age at diagnosis. The majority was female (65%), Hispanic (54%) and had a family history of T2D (92%). The median body mass index ( BMI ) z‐score was 2.3 (interquartile range 2.0–2.6). Fewer than half (46%) lived with both parents, only 30% had parents with education beyond high school, and 43% lived in a household with an income of <$25 000 per year. In the initial month after diagnosis, almost all (92%) were treated with insulin (30%), metformin (31%), or a combination of insulin and metformin (32%); 7% were treated with lifestyle modification alone. Conclusions The demographics of T2D in youth indicate significant social vulnerability which may affect outcomes. Metformin and insulin were the initial treatment in most youth. Importantly, T2D may occur at younger ages than previously thought and should be considered in all high‐risk children presenting with diabetes.